Prognostic factors | Univariate | Multivariate | ||
---|---|---|---|---|
HR (95% CI) | p value | HR (95% CI) | p value | |
Borrmann type | 1.389 (1.264–1.528) | < 0.001 | 1.138 (1.032–1.255) | 0.010 |
Gender | 1.021 (0.895–1.166) | 0.755 |  |  |
Age | 1.085 (0.961–1.225) | 0.189 |  |  |
Tumor size | 1.683 (1.485–1.906) | < 0.001 | – | – |
Tumor location | 1.006 (0.943–1.073) | 0.857 |  |  |
Histologic type | 1.288 (1.123–1.477) | < 0.001 | – | – |
Curative resection | 2.160 (1.849–2.524) | < 0.001 | 1.240 (1.038–1.482) | 0.018 |
T stages | 1.573 (1.463–1.690) | < 0.001 |  |  |
N stages | 1.429 (1.362–1.498) | < 0.001 |  |  |
M stages | 2.214 (1.900–2.580) | < 0.001 |  |  |
TNM stages | 1.938 (1.773–2.118) | < 0.001 | 1.721 (1.555–1.904) | < 0.001 |
Lymphovascular invasion | 1.418 (1.225–1.640) | < 0.001 | – | – |
Nerve invasion | 1.149 (0.972–1.357) | 0.104 |  |  |
Postoperative chemotherapy | 0.615 (0.540–0.699) | < 0.001 | 0.685 (0.602–0.780) | < 0.001 |